PeptidePedia The community reference

Contributions of BetaCellBoyd

User contributions·36 logged edits·page 1 of 1

Contributions by BetaCellBoyd, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,866 edits includes activity predating the current log.

  1. 01:10, 19 Jul 2026 (diff | hist) Third-party testing 7,489 ±0 expand §Sampling and representativeness
  2. 16:22, 16 Jul 2026 (diff | hist) Dipeptidyl peptidase-4 7,022 ±0 m state that the enzyme inhibitor class works by raising endogenous levels
  3. 10:25, 5 Jun 2026 (diff | hist) Talk:C-peptide 537 +174 /* Measured on treatment */ new section
  4. 22:30, 1 Jun 2026 (diff | hist) Gastric emptying 5,565 ±0 m split §Physiology from §Pharmacological exploitation
  5. 16:40, 24 Apr 2026 (diff | hist) Talk:Insulin secretion 748 +175 /* Beta-cell mass at diagnosis: the number keeps changing */ reply
  6. 10:11, 10 Apr 2026 (diff | hist) Dipeptidyl peptidase-4 7,022 ±0 rm the causal claim about appetite — the cited work is associative
  7. 14:30, 11 Mar 2026 (diff | hist) Talk:Amylin 611 +173 /* Amyloid: cause or consequence? */ reply
  8. 14:47, 8 Mar 2026 (diff | hist) Talk:Beta cell function 748 +177 /* The word "restores" */ reply
  9. 13:25, 4 Mar 2026 (diff | hist) Talk:Hypoglycaemia 611 +96 /* Mechanistic argument is not a guarantee */ reply
  10. 09:18, 20 Feb 2026 (diff | hist) Talk:Insulin secretion 400 +229 /* Trigger versus amplification framing */ new section
  11. 01:34, 11 Feb 2026 (diff | hist) Bacteriostatic water 4,652 ±0 add a second worked example at a different vial strength
  12. 05:18, 4 Jan 2026 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 add the species in which the knockout work was done
  13. 04:03, 14 Dec 2025 (diff | hist) Receptor bias 4,477 ±0 the article treated a rodent finding as human physiology; corrected
  14. 03:18, 1 Nov 2025 (diff | hist) GLP-1 receptor 7,570 ±0 m add the reference range with the assay it was established on
  15. 09:58, 20 Oct 2025 (diff | hist) AmbioPharm 4,333 +925 de-orphan
  16. 04:37, 4 Oct 2025 (diff | hist) Xi'an Mokemei Biotechnology 11,462 +902 de-orphan
  17. 03:32, 3 Oct 2025 (diff | hist) Proglucagon 6,709 ±0 add the reference range with the assay it was established on
  18. 11:48, 24 Aug 2025 (diff | hist) Guangzhou JEEP Biotechnology 13,849 +798 add the outbound storefront link, marked nofollow and sponsored per the external-links convention
  19. 07:08, 10 Aug 2025 (diff | hist) Insulin secretion 6,940 ±0 add the cleavage site by residue number
  20. 12:15, 13 Jun 2025 (diff | hist) Preparative HPLC purification 4,598 ±0 expand §Scale-up
  21. 00:48, 2 Apr 2025 (diff | hist) Third-party testing 5,770 ±0 typo
  22. 05:25, 22 Mar 2025 (diff | hist) Insulin syringe unit conversion 3,664 ±0 m add the assumed syringe scale to the readout label
  23. 17:24, 7 Feb 2025 (diff | hist) Certificate of analysis 6,396 ±0 m add the chain-of-custody point to §Limitations
  24. 07:22, 6 Feb 2025 (diff | hist) Dipeptidyl peptidase-4 5,763 ±0 m distinguish the active and total forms of the hormone throughout
  25. 21:19, 24 Jan 2025 (diff | hist) Glucagon-like peptide-1 10,017 ±0 clarify that the incretin effect is defined by the oral–intravenous comparison
  26. 09:20, 17 Dec 2024 (diff | hist) Residual solvent 2,880 ±0 ce
  27. 01:15, 11 Dec 2024 (diff | hist) Albumin binding half-life extension 4,356 +1,046 the numbers in the lead disagreed with the body; body was right
  28. 04:32, 11 Nov 2024 (diff | hist) Shanghai Sigma-Audley New Material Technology 2,346 ±0 correct the trading name — the short code and the legal name are different things
  29. 20:33, 22 Oct 2024 (diff | hist) Arcuate nucleus 2,700 +353 m expand §Access to circulating signals
  30. 21:45, 16 Oct 2024 (diff | hist) Triple agonist 2,043 ±0 m split §Pharmacology into receptor binding and downstream signalling
  31. 08:10, 26 Sep 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 5,034 ±0 m expand §Biosynthesis and secretion
  32. 09:48, 24 Sep 2024 (diff | hist) Sterile water for injection 2,026 +216 state the number of doses a vial yields at that concentration
  33. 02:53, 2 Sep 2024 (diff | hist) Satiety signalling 2,170 +844 move a stray full stop inside the reference
  34. 23:13, 22 Aug 2024 (diff | hist) Wuhan Wansheng Biotechnology 4,317 ±0 state the city and province of the registered address
  35. 09:00, 14 Aug 2024 (diff | hist) Satiety signalling 1,326 +1,326 N create article — physiology stub
  36. 08:50, 2 Jul 2024 (diff | hist) GLP-1 receptor 2,831 ±0 clarify that the incretin effect is defined by the oral–intravenous comparison